| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.069 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |